PAGE2
gene geneOn this page
Also known as MGC62094PAGE-2CT16.4
Summary
PAGE2 (PAGE family member 2, HGNC:31804) is a protein-coding gene on chromosome Xp11.21, encoding P antigen family member 2 (Q7Z2X7).
At a glance
- GWAS associations: 2
- Clinical variants (ClinVar): 23 total — 1 likely-pathogenic
- MANE Select transcript:
NM_207339
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:31804 |
| Approved symbol | PAGE2 |
| Name | PAGE family member 2 |
| Location | Xp11.21 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | MGC62094, PAGE-2, CT16.4 |
| Ensembl gene | ENSG00000234068 |
| Ensembl biotype | protein_coding |
| OMIM | 300738 |
| Entrez | 203569 |
Gene structure
Transcript identifiers
Ensembl transcripts: 3 — 3 protein_coding
ENST00000374965, ENST00000374968, ENST00000449097
RefSeq mRNA: 1 — MANE Select: NM_207339
NM_207339
CCDS: CCDS14367
Canonical transcript exons
ENST00000374968 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001601750 | 55089018 | 55089103 |
| ENSE00001610680 | 55091332 | 55091457 |
| ENSE00001719761 | 55092715 | 55092842 |
| ENSE00001801056 | 55090013 | 55090104 |
| ENSE00003784542 | 55090502 | 55090610 |
Expression profiles
Bgee: expression breadth ubiquitous, 113 present calls, max score 94.36.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.1398 / max 81.3784, expressed in 17 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 196455 | 0.1050 | 17 |
| 196456 | 0.0182 | 8 |
| 196457 | 0.0165 | 6 |
Top tissues by expression
133 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 94.36 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 90.72 | gold quality |
| right testis | UBERON:0004534 | 89.22 | gold quality |
| testis | UBERON:0000473 | 88.12 | gold quality |
| left testis | UBERON:0004533 | 87.17 | gold quality |
| placenta | UBERON:0001987 | 51.65 | gold quality |
| mucosa of stomach | UBERON:0001199 | 47.07 | gold quality |
| granulocyte | CL:0000094 | 46.68 | silver quality |
| bone marrow cell | CL:0002092 | 45.87 | gold quality |
| blood | UBERON:0000178 | 44.87 | gold quality |
| left coronary artery | UBERON:0001626 | 43.15 | gold quality |
| cortical plate | UBERON:0005343 | 43.11 | gold quality |
| bone marrow | UBERON:0002371 | 42.20 | gold quality |
| skin of leg | UBERON:0001511 | 40.66 | gold quality |
| zone of skin | UBERON:0000014 | 40.40 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 40.30 | silver quality |
| left ovary | UBERON:0002119 | 40.16 | gold quality |
| skin of abdomen | UBERON:0001416 | 40.14 | gold quality |
| cerebellar cortex | UBERON:0002129 | 40.01 | silver quality |
| cerebellum | UBERON:0002037 | 39.74 | silver quality |
| ovary | UBERON:0000992 | 39.55 | gold quality |
| spleen | UBERON:0002106 | 39.02 | gold quality |
| right uterine tube | UBERON:0001302 | 38.76 | silver quality |
| tibial artery | UBERON:0007610 | 38.50 | gold quality |
| popliteal artery | UBERON:0002250 | 38.31 | gold quality |
| ganglionic eminence | UBERON:0004023 | 37.68 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 37.22 | silver quality |
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| right ovary | UBERON:0002118 | 36.95 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 36.62 | gold quality |
Single-cell (SCXA)
Detected in 5 experiment(s), a significant marker in 3.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-6308 | yes | 938.92 |
| E-ENAD-20 | yes | 204.05 |
| E-GEOD-134144 | yes | 31.49 |
| E-GEOD-110499 | no | 120.59 |
| E-ANND-3 | no | 1.13 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
9 targeting PAGE2, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-5582-3P | 99.86 | 72.48 | 4221 |
| HSA-MIR-3180-5P | 99.82 | 69.12 | 2422 |
| HSA-MIR-29B-2-5P | 99.67 | 68.98 | 1726 |
| HSA-MIR-3123 | 99.47 | 67.15 | 2693 |
| HSA-MIR-6507-5P | 99.36 | 70.46 | 2524 |
| HSA-MIR-520A-5P | 99.35 | 66.72 | 1632 |
| HSA-MIR-525-5P | 99.35 | 66.85 | 1615 |
| HSA-MIR-488-5P | 99.28 | 68.12 | 821 |
| HSA-MIR-4477A | 98.83 | 69.75 | 2952 |
Literature-anchored findings (GeneRIF, showing 1)
- Epigenetic mechanisms underlying the dynamic expression of cancer-testis genes, PAGE2, -2B and SPANX-B, during mesenchymal-to-epithelial transition (PMID:25229454)
Cross-species orthologs
0 orthologs
Paralogs (22): PAGE1 (ENSG00000068985), PAGE4 (ENSG00000101951), XAGE2 (ENSG00000155622), PAGE5 (ENSG00000158639), XAGE3 (ENSG00000171402), XAGE5 (ENSG00000171405), GAGE2A (ENSG00000189064), PAGE3 (ENSG00000204279), XAGE1A (ENSG00000204379), XAGE1B (ENSG00000204382), GAGE1 (ENSG00000205777), GAGE12G (ENSG00000215269), GAGE10 (ENSG00000215274), GAGE12E (ENSG00000216649), GAGE12J (ENSG00000224659), GAGE12H (ENSG00000224902), GAGE12D (ENSG00000227488), GAGE12F (ENSG00000236362), GAGE12C (ENSG00000237671), PAGE2B (ENSG00000238269), GAGE13 (ENSG00000274274), GAGE2E (ENSG00000275113)
Protein
Protein identifiers
P antigen family member 2 — Q7Z2X7 (reviewed: Q7Z2X7)
Alternative names: G antigen family C 2, Prostate-associated gene 2 protein
All UniProt accessions (3): Q7Z2X7, X6R922, X6RD31
UniProt curated annotations — full annotation on UniProt →
Similarity. Belongs to the GAGE family.
RefSeq proteins (1): NP_997222* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR008625 | GAGE_fam | Family |
| IPR031320 | GAGE | Domain |
Pfam: PF05831
UniProt features (4 total): chain 1, region of interest 1, compositionally biased region 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q7Z2X7-F1 | 61.33 | 0.00 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 8 (showing top):
BIDUS_METASTASIS_UP, ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN, chrXp11, MIR5582_3P, MIR4477A, MIR3180_5P, SU_HO_CONV_CENT_CHONDROSARCOMA_LEUKOCYTE_C4_OSTEOCLAST, NEWMAN_ERCC6_TARGETS_DN
GO Biological Process (0):
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (0):
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| binding | 1 |
Protein interactions and networks
STRING
64 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| PAGE2 | PAGE1 | O75459 | 945 |
| PAGE2 | SPANXA1 | Q9NS26 | 436 |
| PAGE2 | SPANXD | Q9BXN6 | 378 |
| PAGE2 | SPANXB1 | Q9NS25 | 353 |
| PAGE2 | MOB2 | Q70IA6 | 327 |
| PAGE2 | CTAG2 | O75638 | 250 |
| PAGE2 | MAGEB3 | O15480 | 244 |
| PAGE2 | PAGE4 | O60829 | 219 |
| PAGE2 | ENTREP3 | P81408 | 215 |
| PAGE2 | MAGEB2 | O15479 | 204 |
| PAGE2 | TGM1 | P22735 | 202 |
| PAGE2 | APOL5 | Q9BWW9 | 201 |
| PAGE2 | TP53RK | Q96S44 | 199 |
| PAGE2 | TPRKB | Q9Y3C4 | 198 |
| PAGE2 | KPNA4 | O00629 | 198 |
IntAct
13 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| PAGE2 | MEOX2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MEOX2 | PAGE2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TINF2 | PAGE2 | psi-mi:“MI:0915”(physical association) | 0.510 |
| PAGE2 | PAGE5 | psi-mi:“MI:0915”(physical association) | 0.400 |
| PAGE2 | HSP90AB4P | psi-mi:“MI:0915”(physical association) | 0.400 |
| ZBTB8OS | PAGE2 | psi-mi:“MI:0915”(physical association) | 0.400 |
| TERF1 | PAGE2 | psi-mi:“MI:0915”(physical association) | 0.370 |
| ACD | PAGE2 | psi-mi:“MI:0915”(physical association) | 0.370 |
| POT1 | PAGE2 | psi-mi:“MI:0915”(physical association) | 0.370 |
| SHLD3 | psi-mi:“MI:0914”(association) | 0.350 | |
| PAGE2 | TINF2 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (8): PAGE2 (Two-hybrid), PAGE5 (Affinity Capture-MS), PAGE2 (Affinity Capture-MS), HSP90AB4P (Affinity Capture-MS), PAGE2 (Two-hybrid), PAGE2 (Two-hybrid), PAGE2 (Two-hybrid), PAGE2 (Two-hybrid)
ESM2 similar proteins: A0A0U1RQG5, A1L429, A6NDE8, A6NER3, A6NGK3, E1AZ71, O08664, O60829, O75459, O76087, P0C2W7, P0CL80, P0CL81, P0CL82, P0DSO3, P0DTW1, P52651, P62521, P86478, P86479, P86480, P86481, P86496, Q13066, Q13069, Q13070, Q17QW4, Q28181, Q2T9P9, Q32PA2, Q4V321, Q4V326, Q5JQC4, Q5U2Y8, Q62100, Q63803, Q64256, Q6NT46, Q6X7S9, Q7Z2X7
Diamond homologs: O75459, Q5JRK9, Q5JUK9, Q7Z2X7, Q8WTP9, Q8WWM1, Q96GT9, Q96GU1, A6NGK3, A1L429, A6NDE8, A6NER3, O76087, P0CL80, P0CL81, P0CL82, P0DSO3, P0DTW1, Q13066, Q13069, Q13070, Q4V321, Q4V326, Q6NT46, Q9UEU5, Q9HD64
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
23 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 1 |
| Uncertain significance | 13 |
| Likely benign | 4 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (1)
| Variant ID | HGVS | Classification |
|---|---|---|
| 1526799 | GRCh37/hg19 Xp11.22-11.21(chrX:52881435-55684871) | Likely pathogenic |
SpliceAI
552 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| X:55089100:GCCG:G | donor_gain | 1.0000 |
| X:55090011:A:AG | acceptor_gain | 1.0000 |
| X:55090011:AGT:A | acceptor_gain | 1.0000 |
| X:55090011:AGTG:A | acceptor_gain | 1.0000 |
| X:55090012:G:GA | acceptor_gain | 1.0000 |
| X:55090012:GT:G | acceptor_gain | 1.0000 |
| X:55090012:GTG:G | acceptor_gain | 1.0000 |
| X:55090012:GTGG:G | acceptor_gain | 1.0000 |
| X:55090101:GATT:G | donor_gain | 1.0000 |
| X:55090105:G:GG | donor_gain | 1.0000 |
| X:55090617:G:GT | donor_gain | 1.0000 |
| X:55090619:A:T | donor_gain | 1.0000 |
| X:55090644:G:GA | donor_gain | 1.0000 |
| X:55091328:TAA:T | acceptor_loss | 1.0000 |
| X:55091329:AAG:A | acceptor_gain | 1.0000 |
| X:55091329:AAGG:A | acceptor_gain | 1.0000 |
| X:55091330:A:AG | acceptor_gain | 1.0000 |
| X:55091330:A:AT | acceptor_loss | 1.0000 |
| X:55091331:G:A | acceptor_gain | 1.0000 |
| X:55091331:G:GC | acceptor_loss | 1.0000 |
| X:55091331:G:GG | acceptor_gain | 1.0000 |
| X:55091411:G:GT | donor_gain | 1.0000 |
| X:55091412:G:T | donor_gain | 1.0000 |
| X:55091455:CAG:C | donor_loss | 1.0000 |
| X:55091456:AG:A | donor_loss | 1.0000 |
| X:55091457:GGTT:G | donor_loss | 1.0000 |
| X:55091458:GTTT:G | donor_loss | 1.0000 |
| X:55091459:T:G | donor_loss | 1.0000 |
| X:55089102:CGG:C | donor_loss | 0.9900 |
| X:55089104:G:A | donor_loss | 0.9900 |
AlphaMissense
726 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| X:55091430:T:C | F98L | 0.646 |
| X:55091432:T:A | F98L | 0.646 |
| X:55091432:T:G | F98L | 0.646 |
dbSNP variants (sampled 300 via entrez): RS1005641599 (X:55088027 G>T), RS1005695482 (X:55088516 CAG>C), RS1005975021 (X:55089938 A>G,T), RS1006026095 (X:55090364 A>G), RS1006579739 (X:55088974 G>A), RS1006672871 (X:55089230 A>C), RS1006882752 (X:55087340 T>C,G), RS1008298580 (X:55091185 C>A,G,T), RS1011576250 (X:55087183 C>T), RS1012291547 (X:55088149 G>T), RS1012831215 (X:55088487 T>TAA), RS1013492515 (X:55089894 C>A), RS1015775633 (X:55088031 C>T), RS1015788484 (X:55088562 C>T), RS1016533739 (X:55090364 ATCATC>A)
Disease associations
OMIM: gene MIM:300738 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
2 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST90002390_292 | Mean corpuscular hemoglobin | 2.000000e-21 |
| GCST90002392_239 | Mean corpuscular volume | 1.000000e-16 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004527 | mean corpuscular hemoglobin |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
10 total (human), top 10 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| bisphenol A | increases methylation | 1 |
| hydroxyhydroquinone | decreases expression | 1 |
| zinc chromate | increases abundance, increases expression | 1 |
| chromium hexavalent ion | increases abundance, increases expression | 1 |
| Decitabine | increases expression | 1 |
| Acetaminophen | decreases expression | 1 |
| Benzo(a)pyrene | decreases methylation | 1 |
| Cadmium | decreases expression | 1 |
| Silicon Dioxide | increases expression | 1 |
| Cadmium Chloride | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.